𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study

✍ Scribed by Martín-Liberal, J.; López-Pousa, A.; Broto, J. Martín; Cubedo, R.; Gallego, O.; Brendel, E.; Tirado, O. M.; Muro, X. García

Book ID
121700766
Publisher
Springer US
Year
2013
Tongue
English
Weight
293 KB
Volume
32
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential dose-dense doxorubicin and if
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas : A Phase II Trial by the Spanish Group for Research on Sarcomas (GEIS)
✍ Joan Maurel; Joaquín Fra; Antonio López-Pousa; Xavier García del Muro; Carmen Ba 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND Combinations of high‐dose ifosfamide (IF; 10–12 g/m^2^) plus doxorubicin (DX; 50–90 mg/m^2^) have been administered to patients with advanced soft tissue sarcoma (ASTS) in an attempt to improve therapeutic efficacy. Although these combination regimens appear to yield high